Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Asian Biomedicine
Volume 16 (2022): Issue 3 (June 2022)
Open Access
Uterine tumor resembling ovarian sex-cord tumor: case report and review of the literature
Rong Xu
Rong Xu
,
Liping Shao
Liping Shao
,
Wenling Zhang
Wenling Zhang
and
Zhi-Long Yang
Zhi-Long Yang
| Jun 30, 2022
Asian Biomedicine
Volume 16 (2022): Issue 3 (June 2022)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Clinical report
Published Online:
Jun 30, 2022
Page range:
145 - 150
DOI:
https://doi.org/10.2478/abm-2022-0018
Keywords
case reports
,
fertility preservation
,
immunohistochemistry
,
surgery
,
uterine neoplasms
© 2022 Rong Xu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Pelvic computed tomography image showing an unclear defined 11 cm pelvic mass without further abnormalities.
Figure 2
Magnetic resonance imaging and macroscopic findings. (A) T2-weighted image and (B) diffusion-weighted image depicting a high signal intensity in the uterine fibroid.
Figure 3
Dense long spindle cell configurations and hyaline stromal changes under hematoxylin and eosin staining. (A) 40× (scale bar 250 μm), (B) 100× (scale bar 100 μm), (C) 400× (scale bar 50 μm), and (D) 400× (scale bar 50 μm).
Figure 4
Immunohistochemistry of the UTROSCT. The tumor was positive for (A) CD10 (2+), (B) CD99 (3+), (C) CD34 (+), (D) desmin (3+), (E) ER (3+), (F) PR (3+), (G) SMA (3+), and (H) Ki67 (15%+); magnification: 100× (scale bar 100 μm). The antibodies used were as follows: anti-calretinin (catalog No. CCR-0221, Sainuote Biological Technology Co., China; 1:50); anti-CD10 (catalog No. C6D1; Sainuote Biological Technology; 1:50), anti-CD117 (catalog No. EP10, Sainuote Biological Technology; 1:50), anti-CD99 (clone: 013; catalog No. GT212302, Sainuote Biological Technology; 1:50), anti-CD34 (clone: QBend/10; Sainuote Biological Technology; 1:50), anti-D2-40 (catalog No. D2-40, Sainuote Biological Technology; 1:50), anti-desmin (catalog No. C3B7, Sainuote Biological Technology; 1:50), anti-ER (catalog No. FNab02822, Wuhan Feieng Biological Technology Co., China; 1:50), anti-PR (catalog No. YZK7169, Shanghai Yanzhun Biological Technology Co., China; 1:50), anti-SMA (catalog No. C1C1; Sainuote Biological Technology; 1:50), and anti-Ki67 (catalog No. C3G4, Sainuote Biological Technology; 1:50). ER, estrogen receptor; PR, progesterone receptor; SMA, α smooth muscle actin (actin α-2 (ACTA2)); UTROSCT, uterine tumor resembling ovarian sex-cord tumor.